Treatment Decisions of World Health Organization Grade II and III Ependymomas in Molecular Era.

Related Articles

Treatment Decisions of World Health Organization Grade II and III Ependymomas in Molecular Era.

J Korean Neurosurg Soc. 2018 May;61(3):312-318

Authors: Jung TY, Jung S, Kook H, Baek HJ

Abstract
Surgery and radiotherapy are mainstays of treatment for ependymomas (EPNs). Recent molecular subgrouping could be superior to histopathological grading for predicting the prognosis of patients with EPNs. Gross total resection is an effective treatment approach regardless of its locations or pathologic grades. Adjuvant therapeutic strategies could be decided based on molecular subgrouping with risk-stratification. Information of histologic-molecular biology is now providing clues to therapeutic insights.

PMID: 29742878 [PubMed]

https://ift.tt/2KbM8ye